Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway

Surgery

Volumn 138, Issue 2, 2005, Pages 180-186

  Roztocil, Elisa ^a   Nicholl, Suzanne M ^a   Galaria, Irfan I ^a   Davies, Mark G ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMINOCAPROIC ACID; ANTIBODY; APROTININ; CRM 197; DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; ILOMASTAT; LIGAND; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMIN; PLASMIN INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; ASSAY; CELL CULTURE; CELL PROLIFERATION; CELL SURFACE; DNA DETERMINATION; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FIBRINOLYTIC AGENTS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MURIDAE; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLASMIN; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 24344484078     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.06.014     Document Type: Article

References (28)

1. F. Blasi The urokinase receptor: a cell surface regulated chemokine APMIS 107 1999 96 101
2. Y. Parfyonova, O. Plekhanova, and M. Solomatina Contrasting effects of urokinase and tissue type plasminogen activator on neointima formation and vessel remodeling after arterial injury J Vasc Res 41 2004 268 276
3. P. Carmeliet, L. Moons, and J.-M. Herbert Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice Circ Res 81 1997 829 839
4. H.R. Lijnen, B. VanHoef, F. Lupu, L. Moon, P. Carmeliet, and D. Collen Function of the plasminogen/plasmin and MMP systems after vascular injury in mice with targeted inactivation of fibrinolytic genes Arterioscler Thromb Vasc Biol 18 1998 1035 1045
5. V. Stepanova, A. Bobik, and R. Bibilashvity Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain FEBS Lett 414 1997 471 474
6. J.M. Herbert, I. Lamarche, and P. Carmeliet Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells J Biol Chem 272 1997 23585 23591
7. T. Padro, R.M. Mesters, and B. Dankbar The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet derived and basic fibroblast growth factors in human vascular smooth muscle cells J Cell Sci 115 2002 1961 1971
8. W.J. Tanski, A.J. Fegley, E. Roztocil, and M.G. Davies Domain dependent actions of urokinase on smooth muscle cell responses J Vasc Surg 39 2004 214 222
9. S.M. Nicholl, E. Roztocil, Galaria II, and M.G. Davies Plasmin induces smooth muscle cell proliferation J Surg Res 127 2005 39 45
10. C.J. Barnes, and R. Kumar Biology of the epidermal growth factor receptor family Cancer Treat Res 119 2004 1 13
11. G. Carpenter Nuclear localization and possible functions of receptor tyrosine kinases Curr Opin Cell Biol 15 2003 143 148
12. C.J. Pastore, J.M. Isner, P.A. Bacha, M. Kearney, and J.G. Pickering Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo: results of local versus systemic administration Circ Res 77 1995 519 529
13. V.N. Trieu, R.K. Narla, D.E. Myers, and F.M. Uckun EGF-genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model J Cardiovasc Pharmacol 35 2000 595 605
14. A.K. Chan, A. Kalmes, S. Hawkins, G. Daum, and A.W. Clowes Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery J Vasc Surg 37 2003 644 649
15. B.C. Berk Vascular smooth muscle growth: autocrine growth mechanisms Physiol Rev 81 2001 999 1030
16. G. Raab, and M. Klagsbrun Heparin-binding EGF-like growth factor Biochim Biophys Acta 1333 1997 F179 F199
17. G.E. Bresner, D. Whelton, M.A. Crissman-Combs, C.L. Steffen, G.Y. Kim, and D.R. Brigstock Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase or synthetic heparin-binding HB-EGF fragments Growth Factors 7 1992 289 296
18. A. Nakata, J. Miyagawa, and S.N. Yamashita Localization of heparin binding growth factor-like growth factor in human coronary arteries: possible roles of HB-EGF in the formation of coronary atherosclerosis Circulation 994 1996 2778 2786
19. T.J. Reape, V.J. Wilson, J.M. Kanczler, J.P. Ward, K.G. Burnard, and C.R. Thomas Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue J Mol Cell Cardiol 29 1997 1639 1648
20. T. Igura, S. Kawata, and J. Miyagawa Expression of HB-EGF-like growth factor in neointimal cells induced by balloon injury in rat carotid arteries Arterioscler Thromb Vasc Biol 16 1996 1524 1531
21. J. Miyagawa, S. Higashiyama, and S. Kawata Localization of heparin EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaque J Clin Invest 95 1995 404 411
22. R. Wetzker, and F.D. Bohmer Transactivation joins multiple tracks to the ERK/MAPK cascade Nat Rev Mol Cell Biol 4 2003 651 657
23. K.L. Pierce, A. Tohgo, S. Ahn, M.E. Field, L.M. Luttrell, and R.J. Lefkowitz Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding J Biol Chem 276 2001 23155 23160
24. N. Prenzel, E. Zwick, and H. Daub EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 1999 884 888
25. M. Suzuki, G. Raab, M.A. Moses, C.A. Fernandez, and M. Klagsbrun Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site J Biol Chem 272 1997 31730 31737
26. G. Murphy Matrix metalloproteinases and their inhibitors Acta Orthop Scand 66 Suppl 256 1995 55 60
27. H.R. Lijnen, and D. Collen Matrix metalloproteinase system deficiencies and matrix degradation Thromb Haemost 82 1999 837 845
28. R.D. Kenagy, B.B. Vesti, and A.W. Clowes The urokinase receptor mediates basic fibroblast growth factor dependent smooth muscle cell migration through baboon aortic explants Atherosclerosis 162 2002 63 67